Compare HSIC & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HSIC | BRKR |
|---|---|---|
| Founded | 1932 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 7.3B |
| IPO Year | 1995 | 2000 |
| Metric | HSIC | BRKR |
|---|---|---|
| Price | $76.05 | $47.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | ★ $76.50 | $49.42 |
| AVG Volume (30 Days) | 1.2M | ★ 2.0M |
| Earning Date | 11-04-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.42% |
| EPS Growth | ★ 30.70 | N/A |
| EPS | ★ 3.17 | N/A |
| Revenue | ★ $12,938,000,000.00 | $3,438,900,000.00 |
| Revenue This Year | $5.35 | $3.55 |
| Revenue Next Year | $3.34 | $1.49 |
| P/E Ratio | $24.03 | ★ N/A |
| Revenue Growth | 3.51 | ★ 6.10 |
| 52 Week Low | $60.56 | $28.53 |
| 52 Week High | $82.49 | $64.64 |
| Indicator | HSIC | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 58.78 | 59.74 |
| Support Level | $76.27 | $47.52 |
| Resistance Level | $78.10 | $49.15 |
| Average True Range (ATR) | 1.28 | 1.71 |
| MACD | -0.21 | -0.05 |
| Stochastic Oscillator | 64.19 | 75.01 |
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.